Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

HIV and viral hepatitis coinfection analysis using surveillance data from 15 US states and two cities.

Bosh KA, Coyle JR, Hansen V, Kim EM, Speers S, Comer M, Maddox LM, Khuwaja S, Zhou W, Jatta A, Mayer R, Brantley AD, Muriithi NW, Bhattacharjee R, Flynn C, Bouton L, John B, Keusch J, Barber CA, Sweet K, Ramaswamy C, Westheimer EF, VanderBusch L, Nishimura A, Vu A, Hoffman-Arriaga L, Rowlinson E, Carter AO, Yerkes LE, Li W, Reuer JR, Stockman LJ, Tang T, Brooks JT, Teshale EH, Hall HI.

Epidemiol Infect. 2018 May;146(7):920-930. doi: 10.1017/S0950268818000766. Epub 2018 Apr 11.

2.
4.
6.

Are primary care practitioners in Barbados following hypertension guidelines? - a chart audit.

Adams OP, Carter AO.

BMC Res Notes. 2010 Nov 22;3:316. doi: 10.1186/1756-0500-3-316.

7.
8.

Use of mobile phones by medical staff at Queen Elizabeth Hospital, Barbados: evidence for both benefit and harm.

Ramesh J, Carter AO, Campbell MH, Gibbons N, Powlett C, Moseley H Sr, Lewis D, Carter T.

J Hosp Infect. 2008 Oct;70(2):160-5. doi: 10.1016/j.jhin.2008.06.007. Epub 2008 Aug 12.

PMID:
18701190
9.

Risk behaviour, healthcare access and prevalence of infection with Chlamydia trachomatis and Neisseria gonorrhoeae in a population-based sample of adults in Barbados.

Adams OP, Carter AO, Prussia P, McIntyre G, Branch SL.

Sex Transm Infect. 2008 Jun;84(3):192-4. doi: 10.1136/sti.2007.028126. Epub 2008 Feb 27.

PMID:
18305122
10.

For the patient. obesity and overweight in Barbados.

Adams OP, Lynch-Prescod JT, Carter AO.

Ethn Dis. 2006 Spring;16(2):590. No abstract available.

PMID:
17682270
11.

Obesity in primary care in Barbados: prevalence and perceptions.

Adams OP, Lynch-Prescod JT, Carter AO.

Ethn Dis. 2006 Spring;16(2):384-90.

PMID:
17682239
13.

Author's response: a survey identified publication bias in the secondary literature.

Carter AO, Carter TP, Griffin GH.

J Clin Epidemiol. 2007 Apr;60(4):425. Epub 2006 Dec 11. No abstract available.

PMID:
17346618
14.

Epilepsy and antiepileptic drug use in elderly people as risk factors for dementia.

Carter MD, Weaver DF, Joudrey HR, Carter AO, Rockwood K.

J Neurol Sci. 2007 Jan 31;252(2):169-72. Epub 2006 Dec 19.

PMID:
17182059
15.

Prevalence and correlates of HIV serostatus disclosure: a prospective study among HIV-infected postparturient women in Barbados.

Kumar A, Waterman I, Kumari G, Carter AO.

AIDS Patient Care STDS. 2006 Oct;20(10):724-30.

PMID:
17052142
16.
17.

Prevalence and risk factors associated with obesity in the elderly in Barbados.

Carter AO, Hambleton IR, Broome HL, Fraser HS, Hennis AJ.

J Aging Health. 2006 Apr;18(2):240-58.

PMID:
16614343
18.
19.

A survey identified publication bias in the secondary literature.

Carter AO, Griffin GH, Carter TP.

J Clin Epidemiol. 2006 Mar;59(3):241-5. Review.

PMID:
16488354
20.
21.

Efficacy of highly active antiretroviral therapy in nonclinical trial setting of a developing Caribbean country.

Kumar A, Kilaru KR, Sippy N, Carter AO, Roach TC.

J Acquir Immune Defic Syndr. 2005 Sep 1;40(1):114-6. No abstract available.

PMID:
16123695
22.

A controlled before-after trial of structured diabetes care in primary health centres in a newly developed country.

Reed RL, Revel AD, Carter AO, Saadi HF, Dunn EV.

Int J Qual Health Care. 2005 Aug;17(4):281-6. Epub 2005 Apr 14.

PMID:
15831543
23.

Bone density estimates and risk factors for osteoporosis in young women.

Saadi HF, Reed RL, Carter AO, Qazaq HS, Al-Suhaili AR.

East Mediterr Health J. 2001 Jul-Sep;7(4-5):730-7.

24.
25.

Assessment of obesity, lifestyle, and reproductive health needs of female citizens of Al Ain, United Arab Emirates.

Carter AO, Saadi HF, Reed RL, Dunn EV.

J Health Popul Nutr. 2004 Mar;22(1):75-83.

PMID:
15190815
26.

Evaluation of effectiveness of safety seatbelt legislation in the United Arab Emirates.

El-Sadig M, Sarfraz Alam M, Carter AO, Fares K, Al-Taneuiji HO, Romilly P, Norman JN, Lloyd O.

Accid Anal Prev. 2004 May;36(3):399-404.

PMID:
15003585
27.

Health and lifestyle needs assessment of medical students in the United Arab Emirates.

Carter AO, Elzubeir M, Abdulrazzaq YM, Revel AD, Townsend A.

Med Teach. 2003 Sep;25(5):492-6.

PMID:
14522670
28.

The state of the science and art of practice guidelines development, dissemination and evaluation in Canada.

Graham ID, Beardall S, Carter AO, Tetroe J, Davies B.

J Eval Clin Pract. 2003 May;9(2):195-202.

PMID:
12787183
29.

Quantitative ultrasound of the calcaneus in Arabian women: relation to anthropometric and lifestyle factors.

Saadi HF, Reed RL, Carter AO, Dunn EV, Qazaq HS, Al-Suhaili AR.

Maturitas. 2003 Mar 28;44(3):215-23.

PMID:
12648885
30.

Effect of interpregnancy interval on risk of spontaneous preterm birth in Emirati women, United Arab Emirates.

Al-Jasmi F, Al-Mansoor F, Alsheiba A, Carter AO, Carter TP, Hossain MM.

Bull World Health Organ. 2002;80(11):871-5.

31.

The determinants of breast cancer screening behavior: a focus group study of women in the United Arab Emirates.

Bener A, Honein G, Carter AO, Da'ar Z, Miller C, Dunn EV.

Oncol Nurs Forum. 2002 Oct;29(9):E91-8.

PMID:
12370705
32.

What is the quality of drug therapy clinical practice guidelines in Canada?

Graham ID, Beardall S, Carter AO, Glennie J, Hébert PC, Tetroe JM, McAlister FA, Visentin S, Anderson GM.

CMAJ. 2001 Jul 24;165(2):157-63.

33.

A comparison of clinical practice guideline appraisal instruments.

Graham ID, Calder LA, Hébert PC, Carter AO, Tetroe JM.

Int J Technol Assess Health Care. 2000 Autumn;16(4):1024-38. Review.

PMID:
11155826
34.
35.

Canadian physicians' attitudes about and preferences regarding clinical practice guidelines.

Hayward RS, Guyatt GH, Moore KA, McKibbon KA, Carter AO.

CMAJ. 1997 Jun 15;156(12):1715-23.

36.

Eying guidelines.

Wensel RH, Carter AO, Walters D, Beardall S.

CMAJ. 1996 Dec 15;155(12):1666, 1668. No abstract available.

37.

Physician prescribing practices: What do we know? Where do we go? How do we get there?

Carter AO, Strachan D, Appiah Y.

CMAJ. 1996 Jun 1;154(11):1649-53.

38.

Variability in prescription drug utilization: issues for research.

Anis AH, Carruthers SG, Carter AO, Kierulf J.

CMAJ. 1996 Mar 1;154(5):635-40.

39.

[Public health surveillance: historical origin, methods, and assessment].

Declich S, Carter AO.

Ann Ist Super Sanita. 1996;32(3):317-37. Italian.

PMID:
9103158
40.

Surveillance of vaccine-related adverse events in the first year of life: a Manitoba cohort study.

Roberts JD, Roos LL, Poffenroth LA, Hassard TH, Bebchuk JD, Carter AO, Law B.

J Clin Epidemiol. 1996 Jan;49(1):51-8.

PMID:
8598511
41.

Proceedings of the 1994 Canadian Clinical Practice Guidelines Network Workshop.

Carter AO, Battista RN, Hodge MJ, Lewis S, Haynes RB.

CMAJ. 1995 Dec 15;153(12):1715-9. No abstract available.

42.

Report on activities and attitudes of organizations active in the clinical practice guidelines field.

Carter AO, Battista RN, Hodge MJ, Lewis S, Basinski A, Davis D.

CMAJ. 1995 Oct 1;153(7):901-7.

43.

Monitoring childhood immunizations: a Canadian approach.

Roberts JD, Poffenroth LA, Roos LL, Bebchuk JD, Carter AO.

Am J Public Health. 1994 Oct;84(10):1666-8.

44.

Immunization policies in Canadian medical schools.

Rowan MS, Carter AO, Walker VJ.

CMAJ. 1994 Oct 1;151(7):957-61. Review.

45.

Public health surveillance: historical origins, methods and evaluation.

Declich S, Carter AO.

Bull World Health Organ. 1994;72(2):285-304. Review.

46.

Similar drug names cause concern.

Carter AO.

Can Fam Physician. 1993 Apr;39:754. No abstract available.

47.

Drug nomenclature: special notice from the CMA.

Carter AO.

CMAJ. 1993 Apr 1;148(7):1121. English, French. No abstract available.

48.

Setting priorities: the Canadian experience in communicable disease surveillance.

Carter AO; Centers for Disease Control (CDC).

MMWR Morb Mortal Wkly Rep. 1992 Dec;41 Suppl:79-84. No abstract available.

PMID:
1344268
49.

Hepatitis B Infection in Canada: Epidemiology and implications for control.

Delage G, Carter AO.

Can Fam Physician. 1992 Nov;38:2656-66.

50.

Adverse reactions to the preschool (fifth) dose of adsorbed diphtheria-pertussis-tetanus vaccine in Canadian children.

Scheifele DW, Meekison W, Grace M, Barreto L, Carter AO, Mitchell L, Farley J.

CMAJ. 1991 Sep 15;145(6):641-7.

Supplemental Content

Loading ...
Support Center